The Clorox Company (NYSE:CLX) Shares Sold by Burney Co.

Burney Co. cut its position in The Clorox Company (NYSE:CLXFree Report) by 4.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 4,503 shares of the company’s stock after selling 215 shares during the quarter. Burney Co.’s holdings in Clorox were worth $689,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CLX. Point72 Asset Management L.P. acquired a new stake in shares of Clorox during the fourth quarter valued at about $144,844,000. Norges Bank acquired a new stake in Clorox during the 4th quarter valued at approximately $128,382,000. Parsifal Capital Management LP acquired a new position in shares of Clorox in the 4th quarter valued at approximately $128,245,000. Confluence Investment Management LLC bought a new stake in shares of Clorox in the first quarter worth $135,630,000. Finally, International Assets Investment Management LLC grew its holdings in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Up 7.4 %

Shares of CLX stock traded up $9.95 during trading hours on Friday, reaching $144.09. 2,902,055 shares of the stock traded hands, compared to its average volume of 1,222,022. The business has a fifty day moving average price of $133.90 and a 200 day moving average price of $142.40. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The firm has a market capitalization of $17.89 billion, a PE ratio of 74.65, a PEG ratio of 1.97 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 382.58% and a net margin of 3.95%. The firm had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. On average, equities research analysts forecast that The Clorox Company will post 6.4 EPS for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.39%. The ex-dividend date is Tuesday, August 13th. This is a positive change from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio is currently 248.71%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research reports. TD Cowen initiated coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Deutsche Bank Aktiengesellschaft raised their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday. Barclays reduced their price target on shares of Clorox from $132.00 to $122.00 and set an “underweight” rating on the stock in a research report on Friday, July 19th. Wells Fargo & Company dropped their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Finally, BNP Paribas initiated coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 target price for the company. Six equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $141.44.

View Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.